Zu den Deals
Gesundheitswesen

Shield HealthCare has sold a majority interest to Henry Schein

Shield Healthcare has sold a majority ownership position to Henry Schein, Inc. (NASDAQ: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners.

Founded in 1957 and headquartered in Valencia, California, Shield is one of the largest independent value-added distributors of essential medical supplies for patients and caregivers managing care in the home. The company’s diversified product catalog includes durable and consumable medical products for a wide range of patient diagnoses, including incontinence, enteral nutrition, ostomy, urology and advanced wound care. Shield operates across a nationwide footprint to provide superior solutions centered around improving patient outcomes and providing exceptional customer service and patient satisfaction.

Henry Schein is a solutions company for healthcare professionals powered by a network of people and technology. With approximately 24,000 members worldwide, the company’s network of trusted advisors provides over one million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Its business, clinical, technology and supply chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional healthcare clinics, as well as other alternate care sites.

Oaklins Intrepid in Los Angeles acted as the exclusive sell-side advisor in this transaction.

Parteien

Sprechen Sie mit dem Deal-Team

Adam Abramowitz

Geschäftsführer
Los Angeles, Vereinigte Staaten
Oaklins Intrepid

Kyle Berkman

Associate Director
Los Angeles, Vereinigte Staaten
Oaklins Intrepid

James Heskett

Associate Director
Los Angeles, Vereinigte Staaten
Oaklins Intrepid

Relevante Transaktionen

Rare Patient Voice has been acquired by Konovo
Gesundheitswesen | Technologie, Medien und Telekommunikation

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

Weitere Informationen
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Gesundheitswesen

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Weitere Informationen
Clinical Partners has raised new debt facilities
Gesundheitswesen

Clinical Partners has raised new debt facilities

Clinical Partners Ltd. has successfully restructured and upsized its debt facilities to better reflect the scale of the business. The company increased its original US$9.4 million facility, comprising a US$3.4 million term loan and a US$6 million revolving credit facility (RCF), to a US$27 million RCF.

Weitere Informationen